{"entity":{"type":"insider","cik":"0001431408","url":"/insider/0001431408","json_url":"/insider/0001431408.json","name":"Leiden Jeffrey","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":7,"first":"2008-09-09","last":"2010-08-20","span_basis":"filed_date"},"name_variants":[{"name":"Leiden Jeffrey","source":"filing","n_filings":7,"first_seen":"2008-09-09","last_seen":"2010-08-20"}],"transactions":[{"id":7624096,"accession":"0001012975-10-000292","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001012975-10-000292","line_url":"/filing/0001012975-10-000292#line-1","is_derivative":false,"issuer_cik":"0001070336","issuer_name":"ACHILLION PHARMACEUTICALS INC","issuer_ticker":"ACHN","issuer_name_source":null,"issuer_url":"/issuer/0001070336","owner_cik":null,"owner_name":"Clarus Ventures II, LLC; Clarus Lifesciences II, L.P.; Simon Nicholas; WHEELER KURT; Clarus Ventures II GP, L.P.; HENNER DENNIS; GALAKATOS NICHOLAS; LIPTAK ROBERT; STEINMETZ MICHAEL; Leiden Jeffrey","owner_display_name":"Clarus Ventures II, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4875502.0,"shares_display":"4,875,502","price_per_share":2.49,"price_display":"2.49","price_state":"stated","total_value":12139999.98,"total_display":"12,139,999.98","total_whole":"12,140,000","shares_owned_after":9262079.0,"shares_owned_after_display":"9,262,079","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-08-20","filed_date":"2010-08-20","scope":"insider"},{"id":7378352,"accession":"0001012975-10-000008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001012975-10-000008","line_url":"/filing/0001012975-10-000008#line-1","is_derivative":false,"issuer_cik":"0001070336","issuer_name":"ACHILLION PHARMACEUTICALS INC","issuer_ticker":"ACHN","issuer_name_source":null,"issuer_url":"/issuer/0001070336","owner_cik":null,"owner_name":"GALAKATOS NICHOLAS; Clarus Ventures II, LLC; Leiden Jeffrey; STEINMETZ MICHAEL; WHEELER KURT; Clarus Lifesciences II, L.P.; Simon Nicholas; HENNER DENNIS; LIPTAK ROBERT; Clarus Ventures II GP, L.P.","owner_display_name":"GALAKATOS NICHOLAS","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":233990.0,"shares_display":"233,990","price_per_share":3.7667,"price_display":"3.77","price_state":"stated","total_value":881370.133,"total_display":"881,370.13","total_whole":"881,370","shares_owned_after":4386577.0,"shares_owned_after_display":"4,386,577","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-01-11","filed_date":"2010-01-13","scope":"insider"},{"id":7761173,"accession":"0001012975-10-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001012975-10-000002","line_url":"/filing/0001012975-10-000002#line-2","is_derivative":false,"issuer_cik":"0001070336","issuer_name":"ACHILLION PHARMACEUTICALS INC","issuer_ticker":"ACHN","issuer_name_source":null,"issuer_url":"/issuer/0001070336","owner_cik":null,"owner_name":"GALAKATOS NICHOLAS; LIPTAK ROBERT; HENNER DENNIS; WHEELER KURT; Clarus Lifesciences II, L.P.; Clarus Ventures II, LLC; Clarus Ventures II GP, L.P.; STEINMETZ MICHAEL; Leiden Jeffrey; Simon Nicholas","owner_display_name":"GALAKATOS NICHOLAS","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3600.0,"shares_display":"3,600","price_per_share":3.5,"price_display":"3.50","price_state":"stated","total_value":12600.0,"total_display":"12,600.00","total_whole":"12,600","shares_owned_after":4620567.0,"shares_owned_after_display":"4,620,567","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-01-07","filed_date":"2010-01-08","scope":"insider"},{"id":7761172,"accession":"0001012975-10-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001012975-10-000002","line_url":"/filing/0001012975-10-000002#line-1","is_derivative":false,"issuer_cik":"0001070336","issuer_name":"ACHILLION PHARMACEUTICALS INC","issuer_ticker":"ACHN","issuer_name_source":null,"issuer_url":"/issuer/0001070336","owner_cik":null,"owner_name":"GALAKATOS NICHOLAS; LIPTAK ROBERT; HENNER DENNIS; WHEELER KURT; Clarus Lifesciences II, L.P.; Clarus Ventures II, LLC; Clarus Ventures II GP, L.P.; STEINMETZ MICHAEL; Leiden Jeffrey; Simon Nicholas","owner_display_name":"GALAKATOS NICHOLAS","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":49400.0,"shares_display":"49,400","price_per_share":3.5027,"price_display":"3.50","price_state":"stated","total_value":173033.38,"total_display":"173,033.38","total_whole":"173,033","shares_owned_after":4624167.0,"shares_owned_after_display":"4,624,167","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-01-06","filed_date":"2010-01-08","scope":"insider"},{"id":5686692,"accession":"0001012975-09-000362","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001012975-09-000362","line_url":"/filing/0001012975-09-000362#line-1","is_derivative":false,"issuer_cik":"0001070336","issuer_name":"ACHILLION PHARMACEUTICALS INC","issuer_ticker":"ACHN","issuer_name_source":null,"issuer_url":"/issuer/0001070336","owner_cik":null,"owner_name":"HENNER DENNIS; WHEELER KURT; Simon Nicholas; LIPTAK ROBERT; Clarus Lifesciences II, L.P.; STEINMETZ MICHAEL; GALAKATOS NICHOLAS; Clarus Ventures II, LLC; Leiden Jeffrey; Clarus Ventures II GP, L.P.","owner_display_name":"HENNER DENNIS","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3600.0,"shares_display":"3,600","price_per_share":3.5264,"price_display":"3.53","price_state":"stated","total_value":12695.04,"total_display":"12,695.04","total_whole":"12,695","shares_owned_after":4673567.0,"shares_owned_after_display":"4,673,567","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-12-24","filed_date":"2009-12-29","scope":"insider"},{"id":5678134,"accession":"0001012975-09-000360","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001012975-09-000360","line_url":"/filing/0001012975-09-000360#line-2","is_derivative":false,"issuer_cik":"0001070336","issuer_name":"ACHILLION PHARMACEUTICALS INC","issuer_ticker":"ACHN","issuer_name_source":null,"issuer_url":"/issuer/0001070336","owner_cik":null,"owner_name":"GALAKATOS NICHOLAS; Leiden Jeffrey; Clarus Ventures II GP, L.P.; Simon Nicholas; WHEELER KURT; HENNER DENNIS; Clarus Ventures II, LLC; STEINMETZ MICHAEL; Clarus Lifesciences II, L.P.; LIPTAK ROBERT","owner_display_name":"GALAKATOS NICHOLAS","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":264900.0,"shares_display":"264,900","price_per_share":3.7049,"price_display":"3.70","price_state":"stated","total_value":981428.01,"total_display":"981,428.01","total_whole":"981,428","shares_owned_after":4677167.0,"shares_owned_after_display":"4,677,167","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-12-23","filed_date":"2009-12-23","scope":"insider"},{"id":5678133,"accession":"0001012975-09-000360","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001012975-09-000360","line_url":"/filing/0001012975-09-000360#line-1","is_derivative":false,"issuer_cik":"0001070336","issuer_name":"ACHILLION PHARMACEUTICALS INC","issuer_ticker":"ACHN","issuer_name_source":null,"issuer_url":"/issuer/0001070336","owner_cik":null,"owner_name":"GALAKATOS NICHOLAS; Leiden Jeffrey; Clarus Ventures II GP, L.P.; Simon Nicholas; WHEELER KURT; HENNER DENNIS; Clarus Ventures II, LLC; STEINMETZ MICHAEL; Clarus Lifesciences II, L.P.; LIPTAK ROBERT","owner_display_name":"GALAKATOS NICHOLAS","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19100.0,"shares_display":"19,100","price_per_share":3.5426,"price_display":"3.54","price_state":"stated","total_value":67663.66,"total_display":"67,663.66","total_whole":"67,664","shares_owned_after":4942067.0,"shares_owned_after_display":"4,942,067","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-12-21","filed_date":"2009-12-23","scope":"insider"},{"id":5775261,"accession":"0001012975-09-000358","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001012975-09-000358","line_url":"/filing/0001012975-09-000358#line-3","is_derivative":false,"issuer_cik":"0001070336","issuer_name":"ACHILLION PHARMACEUTICALS INC","issuer_ticker":"ACHN","issuer_name_source":null,"issuer_url":"/issuer/0001070336","owner_cik":null,"owner_name":"Leiden Jeffrey; STEINMETZ MICHAEL; Simon Nicholas; WHEELER KURT; HENNER DENNIS; Clarus Ventures II, LLC; Clarus Lifesciences II, L.P.; LIPTAK ROBERT; GALAKATOS NICHOLAS; Clarus Ventures II GP, L.P.","owner_display_name":"Leiden Jeffrey","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9900.0,"shares_display":"9,900","price_per_share":3.5,"price_display":"3.50","price_state":"stated","total_value":34650.0,"total_display":"34,650.00","total_whole":"34,650","shares_owned_after":4961167.0,"shares_owned_after_display":"4,961,167","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-12-18","filed_date":"2009-12-18","scope":"insider"},{"id":5775260,"accession":"0001012975-09-000358","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001012975-09-000358","line_url":"/filing/0001012975-09-000358#line-2","is_derivative":false,"issuer_cik":"0001070336","issuer_name":"ACHILLION PHARMACEUTICALS INC","issuer_ticker":"ACHN","issuer_name_source":null,"issuer_url":"/issuer/0001070336","owner_cik":null,"owner_name":"Leiden Jeffrey; STEINMETZ MICHAEL; Simon Nicholas; WHEELER KURT; HENNER DENNIS; Clarus Ventures II, LLC; Clarus Lifesciences II, L.P.; LIPTAK ROBERT; GALAKATOS NICHOLAS; Clarus Ventures II GP, L.P.","owner_display_name":"Leiden Jeffrey","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":129476.0,"shares_display":"129,476","price_per_share":3.5,"price_display":"3.50","price_state":"stated","total_value":453166.0,"total_display":"453,166.00","total_whole":"453,166","shares_owned_after":4971067.0,"shares_owned_after_display":"4,971,067","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-12-17","filed_date":"2009-12-18","scope":"insider"},{"id":5775259,"accession":"0001012975-09-000358","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001012975-09-000358","line_url":"/filing/0001012975-09-000358#line-1","is_derivative":false,"issuer_cik":"0001070336","issuer_name":"ACHILLION PHARMACEUTICALS INC","issuer_ticker":"ACHN","issuer_name_source":null,"issuer_url":"/issuer/0001070336","owner_cik":null,"owner_name":"Leiden Jeffrey; STEINMETZ MICHAEL; Simon Nicholas; WHEELER KURT; HENNER DENNIS; Clarus Ventures II, LLC; Clarus Lifesciences II, L.P.; LIPTAK ROBERT; GALAKATOS NICHOLAS; Clarus Ventures II GP, L.P.","owner_display_name":"Leiden Jeffrey","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":67800.0,"shares_display":"67,800","price_per_share":3.5768,"price_display":"3.58","price_state":"stated","total_value":242507.04,"total_display":"242,507.04","total_whole":"242,507","shares_owned_after":5100543.0,"shares_owned_after_display":"5,100,543","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-12-16","filed_date":"2009-12-18","scope":"insider"},{"id":3124728,"accession":"0001012975-08-000149","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001012975-08-000149","line_url":"/filing/0001012975-08-000149#line-2","is_derivative":false,"issuer_cik":"0001070336","issuer_name":"ACHILLION PHARMACEUTICALS INC","issuer_ticker":"ACHN","issuer_name_source":null,"issuer_url":"/issuer/0001070336","owner_cik":null,"owner_name":"Leiden Jeffrey; Simon Nicholas; HENNER DENNIS; WHEELER KURT; Clarus Ventures II GP, L.P.; LIPTAK ROBERT; STEINMETZ MICHAEL; Clarus Lifesciences II, L.P.; Clarus Ventures II, LLC; GALAKATOS NICHOLAS","owner_display_name":"Leiden Jeffrey","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1600.0,"shares_display":"1,600","price_per_share":2.3694,"price_display":"2.37","price_state":"stated","total_value":3791.04,"total_display":"3,791.04","total_whole":"3,791","shares_owned_after":5307420.0,"shares_owned_after_display":"5,307,420","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-09-08","filed_date":"2008-09-09","scope":"insider"},{"id":3124725,"accession":"0001012975-08-000149","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001012975-08-000149","line_url":"/filing/0001012975-08-000149#line-1","is_derivative":false,"issuer_cik":"0001070336","issuer_name":"ACHILLION PHARMACEUTICALS INC","issuer_ticker":"ACHN","issuer_name_source":null,"issuer_url":"/issuer/0001070336","owner_cik":null,"owner_name":"Leiden Jeffrey; Simon Nicholas; HENNER DENNIS; WHEELER KURT; Clarus Ventures II GP, L.P.; LIPTAK ROBERT; STEINMETZ MICHAEL; Clarus Lifesciences II, L.P.; Clarus Ventures II, LLC; GALAKATOS NICHOLAS","owner_display_name":"Leiden Jeffrey","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3054.0,"shares_display":"3,054","price_per_share":2.1917,"price_display":"2.19","price_state":"stated","total_value":6693.4518,"total_display":"6,693.45","total_whole":"6,693","shares_owned_after":5305820.0,"shares_owned_after_display":"5,305,820","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-09-05","filed_date":"2008-09-09","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001070336","name":"ACHILLION PHARMACEUTICALS INC","url":"/issuer/0001070336","role":"Ten percent owner","n_filings":7,"first_seen":"2008-09-09","last_seen":"2010-08-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001431408","retrieved_at":"2026-08-27T12:46:31+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}